CANKADO

CANKADO Service GmbH (CKD) is one of the few manufacturers that is approved by the German Federal Office for Drugs and Medical Devices (BfArM) as a manufacturer of DiGAs (digital health applications). CKD started as a research project to understand improvement needs in current cancer care. The idea was to develop a system which represented a harmonious extension to the existing care landscape. In cooperation with patients, physicians, as well as nurses’ associations and clinics all over the world an entirely new way of digital support of patients with chronic diseases has been developed. Today, CKD is one of the leading digital medical product manufacturers headquartered in Germany and has extensive experience in the e-Health industry. CKD operates with over 50 employees with 6 offices in four countries and project experience on all continents. An entirely new way of digital support for patients with chronic diseases has been developed in cooperation with patients, physicians, other healthcare professionals, and clinics all over the world. Today, the CANKADO system is the worldwide leading system for multi-lingual support of patients with chronic diseases in routine care and in clinical trials, also offering various digital solutions in the areas of cancer, diabetes, cardiology, surgery, cell therapy, psychology, and nutrition. CKD will lead WP2 on the platform adaptation and installation and additionally will have a key role in the development of the go-to-market model and will contribute to all workpakages. Timo Schinkothe is the CEO of CKD. Hes has been devoted to the diffusion of the healthcare platform. He strongly supports the cooperation with clinical trials. He is completely committed to the wellbeing of patients with chronic diseases through the use of web-based platforms.